Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:24
10/30/20
10/30
16:24
10/30/20
16:24
AAPL

Apple

$108.88 /

-6.17 (-5.36%)

, AMZN

Amazon.com

$3,036.77 /

-179.49 (-5.58%)

, FB

Facebook

$263.75 /

-16.59 (-5.92%)

, GOOG

Alphabet

$1,622.56 /

+58.97 (+3.77%)

, GOOGL

Alphabet Class A

$1,616.28 /

+61.09 (+3.93%)

, CVX

Chevron

$69.52 /

+0.66 (+0.96%)

, XOM

Exxon Mobil

$32.66 /

-0.32 (-0.97%)

, CCL

Carnival

$13.69 /

+0.72 (+5.55%)

, RCL

Royal Caribbean

$56.45 /

+2.71 (+5.04%)

, NCLH

Norwegian Cruise Line

$16.62 /

+0.85 (+5.39%)

, PFE

Pfizer

$35.49 /

+0.215 (+0.61%)

, MYL

Mylan

$14.54 /

+0.16 (+1.11%)

, JNJ

Johnson & Johnson

$137.10 /

-0.005 (-0.00%)

, EQ

Equillium

$6.35 /

+0.36 (+6.01%)

, PLT

Plantronics

$19.49 /

+0.5 (+2.63%)

, MGI

MoneyGram

$5.16 /

+0.68 (+15.18%)

, UA

Under Armour

$12.20 /

+0.155 (+1.29%)

, UAA

Under Armour

$13.85 /

+0.05 (+0.36%)

, TWTR

Twitter

$41.34 /

-11.1099 (-21.18%)

, OPK

Opko Health

$3.52 /

-0.68 (-16.21%)

, TEAM

Atlassian

$191.77 /

-19.23 (-9.11%)

The major averages sunk…

ShowHide Related Items >><<
XOM Exxon Mobil
$32.66 /

-0.32 (-0.97%)

UA Under Armour
$12.20 /

+0.155 (+1.29%)

TWTR Twitter
$41.34 /

-11.1099 (-21.18%)

TEAM Atlassian
$191.77 /

-19.23 (-9.11%)

RCL Royal Caribbean
$56.45 /

+2.71 (+5.04%)

PLT Plantronics
$19.49 /

+0.5 (+2.63%)

PFE Pfizer
$35.49 /

+0.215 (+0.61%)

OPK Opko Health
$3.52 /

-0.68 (-16.21%)

NCLH Norwegian Cruise Line
$16.62 /

+0.85 (+5.39%)

MYL Mylan
$14.54 /

+0.16 (+1.11%)

MGI MoneyGram
$5.16 /

+0.68 (+15.18%)

JNJ Johnson & Johnson
$137.10 /

-0.005 (-0.00%)

GOOGL Alphabet Class A
$1,616.28 /

+61.09 (+3.93%)

GOOG Alphabet
$1,622.56 /

+58.97 (+3.77%)

FB Facebook
$263.75 /

-16.59 (-5.92%)

EQ Equillium
$6.35 /

+0.36 (+6.01%)

CVX Chevron
$69.52 /

+0.66 (+0.96%)

CCL Carnival
$13.69 /

+0.72 (+5.55%)

AMZN Amazon.com
$3,036.77 /

-179.49 (-5.58%)

AAPL Apple
$108.88 /

-6.17 (-5.36%)

AAPL Apple
$108.88 /

-6.17 (-5.36%)

08:43 Today Raymond James
Apple price target raised to $140 from $120 at Raymond James
08:35 Today Canaccord
Apple guidance not given but commentary strong, says Canaccord
08:10 Today DA Davidson
Apple price target raised to $133 from $120 at DA Davidson
08:00 Today Loop Capital
Apple price target lowered to $110 from $115 at Loop Capital
AMZN Amazon.com
$3,036.77 /

-179.49 (-5.58%)

10:16 Today Bernstein
Amazon.com price target raised to $3,700 from $3,400 at Bernstein
09:14 Today R5 Capital
R5 Capital upgrades Amazon to Hold after 'total bust' calling for growth to slow
08:44 Today R5 Capital
Amazon.com upgraded to Hold from Sell at R5 Capital
08:40 Today MKM Partners
Amazon.com price target raised to $3,750 from $3,650 at MKM Partners
FB Facebook
$263.75 /

-16.59 (-5.92%)

08:46 Today Raymond James
Facebook price target raised to $320 from $280 at Raymond James
08:42 Today Canaccord
Facebook price target raised to $330 from $315 at Canaccord
08:42 Today MKM Partners
Facebook price target raised to $330 from $300 at MKM Partners
08:19 Today Wedbush
Facebook price target raised to $320 from $300 at Wedbush
GOOG Alphabet
$1,622.56 /

+58.97 (+3.77%)

08:41 Today Raymond James
Alphabet price target raised to $1,800 from $1,700 at Raymond James
08:21 Today Wedbush
Alphabet price target raised to $1,850 from $1,700 at Wedbush
07:59 Today Oppenheimer
Alphabet price target raised to $1,800 from $1,685 at Oppenheimer
07:59 Today Stifel
Alphabet price target raised to $1,700 from $1,600 at Stifel
GOOGL Alphabet Class A
$1,616.28 /

+61.09 (+3.93%)

08:58 Today MKM Partners
Alphabet price target raised to $1,950 from $1,750 at MKM Partners
08:08 Today Truist
Alphabet price target raised to $2,000 from $1,850 at Truist
CVX Chevron
$69.52 /

+0.66 (+0.96%)

10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
10/20/20
Fly Intel: Top five analyst initiations
10/20/20 Credit Suisse
Chevron reinstated with an Outperform at Credit Suisse
10/14/20 HSBC
Chevron price target lowered to $86 from $93 at HSBC
XOM Exxon Mobil
$32.66 /

-0.32 (-0.97%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 Goldman Sachs
Exxon Mobil upgraded to Neutral from Sell at Goldman Sachs
10/07/20 Societe Generale
SBM Offshore upgraded to Buy from Hold at Societe Generale
09/23/20 Scotiabank
Exxon Mobil upgraded to Sector Perform from Underperform at Scotiabank
CCL Carnival
$13.69 /

+0.72 (+5.55%)

14:47 Today Stifel
CDC lifting 'no sail order' a 'clear positive' for cruise liners, says Stifel
10/16/20 Deutsche Bank
Deutsche sees Covid newsflow remaining drag on cruise stocks
10/07/20 JPMorgan
Royal Caribbean price target raised to $79 from $67 at JPMorgan
10/07/20 JPMorgan
JPMorgan 'incrementally bullish' on cruise stocks, ups Carnival price target
RCL Royal Caribbean
$56.45 /

+2.71 (+5.04%)

07:27 Today Deutsche Bank
Royal Caribbean price target raised to $46 from $43 at Deutsche Bank
10/15/20 Berenberg
Royal Caribbean price target raised to $60 from $45 at Berenberg
NCLH Norwegian Cruise Line
$16.62 /

+0.85 (+5.39%)

10/07/20 JPMorgan
Norwegian Cruise Line price target raised to $22 from $19 at JPMorgan
PFE Pfizer
$35.49 /

+0.215 (+0.61%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
10/23/20 Truist
Pfizer initiated with a Buy at Truist
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
MYL Mylan
$14.54 /

+0.16 (+1.11%)

09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
09/16/20 Raymond James
Mylan exclusivity on Tecfidera generic abruptly ending, says Raymond James
08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
JNJ Johnson & Johnson
$137.10 /

-0.005 (-0.00%)

10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
10/14/20 Cantor Fitzgerald
Johnson & Johnson price target raised to $180 from $168 at Cantor Fitzgerald
10/13/20 Wells Fargo
Emergent selloff on J&J study pause an overreaction, says Wells Fargo
EQ Equillium
$6.35 /

+0.36 (+6.01%)

07/14/20 H.C. Wainwright
Equillium price target raised to $24 from $14 at H.C. Wainwright
07/10/20 Stifel
Equillium transferred with Buy rating, $10 target at Stifel
01/03/20 Stifel
Stifel says Incyte setback means Equillium may have most advanced aGVHD product
PLT Plantronics
$19.49 /

+0.5 (+2.63%)

10/12/20 Northland
Plantronics upgraded to Outperform from Market Perform at Northland
09/15/20
Fly Intel: Top five analyst upgrades
09/15/20 JPMorgan
Plantronics upgraded to Neutral on valuation at JPMorgan
09/15/20 JPMorgan
Plantronics upgraded to Neutral from Underweight at JPMorgan
MGI MoneyGram
$5.16 /

+0.68 (+15.18%)

08/03/20 Evercore ISI
MoneyGram upgraded to In Line from Underperform at Evercore ISI
06/10/20
Fly Intel: Top five analyst downgrades
06/10/20 BofA
Western Union downgraded to Neutral from Buy at BofA
06/02/20 BTIG
Western Union-Money Gram review could note more online competition, says BTIG
UA Under Armour
$12.20 /

+0.155 (+1.29%)

12:41 Today Jefferies
Jefferies ups Under Armour price target to $20 after better than expected report
10/26/20 JPMorgan
Under Armour price target raised to $17 from $12 at JPMorgan
10/23/20 Deutsche Bank
Under Armour price target raised to $13 from $12 at Deutsche Bank
10/21/20 Piper Sandler
Under Armour price target raised to $14 from $10 at Piper Sandler
UAA Under Armour
$13.85 /

+0.05 (+0.36%)

12:37 Today Jefferies
Under Armour price target raised to $20 from $13 at Jefferies
TWTR Twitter
$41.34 /

-11.1099 (-21.18%)

07:55 Today Oppenheimer
Twitter price target raised to $55 from $46 at Oppenheimer
07:21 Today Deutsche Bank
Twitter price target raised to $64 from $56 at Deutsche Bank
06:51 Today Mizuho
Twitter price target raised to $48 from $45 at Mizuho
06:28 Today Barclays
Twitter price target raised to $36 from $30 at Barclays
OPK Opko Health
$3.52 /

-0.68 (-16.21%)

07/31/20 Piper Sandler
Opko Health price target raised to $10 from $6 at Piper Sandler
07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
06/09/20 Piper Sandler
Opko Health price target raised to $4 from $3 at Piper Sandler
06/08/20 Piper Sandler
Opko Health, Pfizer data show IGF-1 normal at ENDO, says Piper Sandler
TEAM Atlassian
$191.77 /

-19.23 (-9.11%)

09:56 Today
Fly Intel: Top five analyst downgrades
08:47 Today Canaccord
Atlassian price target raised to $225 from $200 at Canaccord
07:45 Today DA Davidson
Atlassian price target raised to $235 from $210 at DA Davidson
07:20 Today Truist
Atlassian downgraded to Hold from Buy at Truist
XOM Exxon Mobil
$32.66 /

-0.32 (-0.97%)

UA Under Armour
$12.20 /

+0.155 (+1.29%)

TWTR Twitter
$41.34 /

-11.1099 (-21.18%)

TEAM Atlassian
$191.77 /

-19.23 (-9.11%)

RCL Royal Caribbean
$56.45 /

+2.71 (+5.04%)

PLT Plantronics
$19.49 /

+0.5 (+2.63%)

PFE Pfizer
$35.49 /

+0.215 (+0.61%)

OPK Opko Health
$3.52 /

-0.68 (-16.21%)

NCLH Norwegian Cruise Line
$16.62 /

+0.85 (+5.39%)

MYL Mylan
$14.54 /

+0.16 (+1.11%)

MGI MoneyGram
$5.16 /

+0.68 (+15.18%)

JNJ Johnson & Johnson
$137.10 /

-0.005 (-0.00%)

GOOGL Alphabet Class A
$1,616.28 /

+61.09 (+3.93%)

GOOG Alphabet
$1,622.56 /

+58.97 (+3.77%)

FB Facebook
$263.75 /

-16.59 (-5.92%)

EQ Equillium
$6.35 /

+0.36 (+6.01%)

CVX Chevron
$69.52 /

+0.66 (+0.96%)

CCL Carnival
$13.69 /

+0.72 (+5.55%)

AMZN Amazon.com
$3,036.77 /

-179.49 (-5.58%)

AAPL Apple
$108.88 /

-6.17 (-5.36%)

  • 14
    Oct
  • 28
    Aug
  • 14
    Aug
  • 17
    Jul
  • 06
    May
  • 02
    Apr
XOM Exxon Mobil
$32.66 /

-0.32 (-0.97%)

UA Under Armour
$12.20 /

+0.155 (+1.29%)

TWTR Twitter
$41.34 /

-11.1099 (-21.18%)

TEAM Atlassian
$191.77 /

-19.23 (-9.11%)

PFE Pfizer
$35.49 /

+0.215 (+0.61%)

OPK Opko Health
$3.52 /

-0.68 (-16.21%)

NCLH Norwegian Cruise Line
$16.62 /

+0.85 (+5.39%)

MYL Mylan
$14.54 /

+0.16 (+1.11%)

MGI MoneyGram
$5.16 /

+0.68 (+15.18%)

JNJ Johnson & Johnson
$137.10 /

-0.005 (-0.00%)

GOOGL Alphabet Class A
$1,616.28 /

+61.09 (+3.93%)

GOOG Alphabet
$1,622.56 /

+58.97 (+3.77%)

FB Facebook
$263.75 /

-16.59 (-5.92%)

CVX Chevron
$69.52 /

+0.66 (+0.96%)

CCL Carnival
$13.69 /

+0.72 (+5.55%)

AMZN Amazon.com
$3,036.77 /

-179.49 (-5.58%)

AAPL Apple
$108.88 /

-6.17 (-5.36%)

XOM Exxon Mobil
$32.66 /

-0.32 (-0.97%)

UA Under Armour
$12.20 /

+0.155 (+1.29%)

TWTR Twitter
$41.34 /

-11.1099 (-21.18%)

TEAM Atlassian
$191.77 /

-19.23 (-9.11%)

RCL Royal Caribbean
$56.45 /

+2.71 (+5.04%)

PLT Plantronics
$19.49 /

+0.5 (+2.63%)

PFE Pfizer
$35.49 /

+0.215 (+0.61%)

OPK Opko Health
$3.52 /

-0.68 (-16.21%)

NCLH Norwegian Cruise Line
$16.62 /

+0.85 (+5.39%)

MYL Mylan
$14.54 /

+0.16 (+1.11%)

MGI MoneyGram
$5.16 /

+0.68 (+15.18%)

JNJ Johnson & Johnson
$137.10 /

-0.005 (-0.00%)

GOOG Alphabet
$1,622.56 /

+58.97 (+3.77%)

FB Facebook
$263.75 /

-16.59 (-5.92%)

EQ Equillium
$6.35 /

+0.36 (+6.01%)

CVX Chevron
$69.52 /

+0.66 (+0.96%)

CCL Carnival
$13.69 /

+0.72 (+5.55%)

AMZN Amazon.com
$3,036.77 /

-179.49 (-5.58%)

AAPL Apple
$108.88 /

-6.17 (-5.36%)

XOM Exxon Mobil
$32.66 /

-0.32 (-0.97%)

UAA Under Armour
$13.85 /

+0.05 (+0.36%)

UA Under Armour
$12.20 /

+0.155 (+1.29%)

TWTR Twitter
$41.34 /

-11.1099 (-21.18%)

TEAM Atlassian
$191.77 /

-19.23 (-9.11%)

RCL Royal Caribbean
$56.45 /

+2.71 (+5.04%)

PFE Pfizer
$35.49 /

+0.215 (+0.61%)

OPK Opko Health
$3.52 /

-0.68 (-16.21%)

NCLH Norwegian Cruise Line
$16.62 /

+0.85 (+5.39%)

MYL Mylan
$14.54 /

+0.16 (+1.11%)

MGI MoneyGram
$5.16 /

+0.68 (+15.18%)

JNJ Johnson & Johnson
$137.10 /

-0.005 (-0.00%)

GOOGL Alphabet Class A
$1,616.28 /

+61.09 (+3.93%)

GOOG Alphabet
$1,622.56 /

+58.97 (+3.77%)

FB Facebook
$263.75 /

-16.59 (-5.92%)

CVX Chevron
$69.52 /

+0.66 (+0.96%)

CCL Carnival
$13.69 /

+0.72 (+5.55%)

AMZN Amazon.com
$3,036.77 /

-179.49 (-5.58%)

AAPL Apple
$108.88 /

-6.17 (-5.36%)

AAPL Apple
$108.88 /

-6.17 (-5.36%)

Hot Stocks
GM names Paul Jacobson CFO » 16:16
10/30/20
10/30
16:16
10/30/20
16:16
GM

General Motors

$34.52 /

-0.37 (-1.06%)

, DAL

Delta Air Lines

$30.64 /

-0.14 (-0.45%)

General Motors (GM)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$34.52 /

-0.37 (-1.06%)

DAL Delta Air Lines
$30.64 /

-0.14 (-0.45%)

GM General Motors
$34.52 /

-0.37 (-1.06%)

10/29/20 Wedbush
General Motors could be major player in EV market with Tesla, says Wedbush
10/22/20 JPMorgan
General Motors price target raised to $44 from $36 at JPMorgan
10/22/20 Barclays
General Motors price target raised to $40 from $39 at Barclays
10/21/20 Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
DAL Delta Air Lines
$30.64 /

-0.14 (-0.45%)

10/14/20 Susquehanna
Delta Air Lines delivered on cost guidance, Susquehanna remains Positive
10/07/20 JPMorgan
Delta Air Lines price target raised to $51 from $45 at JPMorgan
09/18/20 Barclays
Delta Air Lines price target raised to $30 from $26 at Barclays
09/15/20 Seaport Global
Delta Air Lines initiated with a Buy at Seaport Global
GM General Motors
$34.52 /

-0.37 (-1.06%)

DAL Delta Air Lines
$30.64 /

-0.14 (-0.45%)

GM General Motors
$34.52 /

-0.37 (-1.06%)

DAL Delta Air Lines
$30.64 /

-0.14 (-0.45%)

GM General Motors
$34.52 /

-0.37 (-1.06%)

DAL Delta Air Lines
$30.64 /

-0.14 (-0.45%)

GM General Motors
$34.52 /

-0.37 (-1.06%)

DAL Delta Air Lines
$30.64 /

-0.14 (-0.45%)

Hot Stocks
Delta Air Lines CFO Jacobson to depart on November 15 to join General Motors » 16:12
10/30/20
10/30
16:12
10/30/20
16:12
DAL

Delta Air Lines

$30.63 /

-0.15 (-0.49%)

, GM

General Motors

$34.39 /

-0.5 (-1.43%)

Ed Bastian, CEO, said in…

Ed Bastian, CEO, said in a regulatory filing, "This week, E.V.P. and Chief Financial Officer Paul Jacobson shared with me that he will move forward with his plans from earlier this year and will be departing Delta effective Nov. 15 to join General Motors as CFO. Earlier this year, Paul delayed his decision to retire from Delta to help address the financial impact of the pandemic. Since then he has led the team that has, among other things, raised nearly $30 billion in liquidity - a cushion that is essential to weathering the storm and positioning Delta to lead the industry in the recovery from the pandemic. He has worked tirelessly throughout this year to save costs and protect our future, and I appreciate his leadership through some of the darkest days of Delta's history. Paul joined Delta in 1997 and was named Chief Financial Officer in 2012. In his time here, he has built a world-class financial team, which will be focused on restoring our investment-grade balance sheet and keeping Delta strong in the months and years to come. We will be conducting a global search for a replacement as well as considering internal candidates. In the interim, Gary Chase, S.V.P. - Business Development & Financial Planning, and Bill Carroll, S.V.P. - Finance & Controller, will serve as Co-Chief Financial Officers, jointly leading the Finance team. Please join me in wishing Paul the very best in the next chapter of his career and thanking him for the great contributions he has made to establish Delta as the leading airline in our industry."

ShowHide Related Items >><<
GM General Motors
$34.39 /

-0.5 (-1.43%)

DAL Delta Air Lines
$30.63 /

-0.15 (-0.49%)

DAL Delta Air Lines
$30.63 /

-0.15 (-0.49%)

10/14/20 Susquehanna
Delta Air Lines delivered on cost guidance, Susquehanna remains Positive
10/07/20 JPMorgan
Delta Air Lines price target raised to $51 from $45 at JPMorgan
09/18/20 Barclays
Delta Air Lines price target raised to $30 from $26 at Barclays
09/15/20 Seaport Global
Delta Air Lines initiated with a Buy at Seaport Global
GM General Motors
$34.39 /

-0.5 (-1.43%)

10/29/20 Wedbush
General Motors could be major player in EV market with Tesla, says Wedbush
10/22/20 JPMorgan
General Motors price target raised to $44 from $36 at JPMorgan
10/22/20 Barclays
General Motors price target raised to $40 from $39 at Barclays
10/21/20 Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
GM General Motors
$34.39 /

-0.5 (-1.43%)

DAL Delta Air Lines
$30.63 /

-0.15 (-0.49%)

GM General Motors
$34.39 /

-0.5 (-1.43%)

DAL Delta Air Lines
$30.63 /

-0.15 (-0.49%)

GM General Motors
$34.39 /

-0.5 (-1.43%)

DAL Delta Air Lines
$30.63 /

-0.15 (-0.49%)

GM General Motors
$34.39 /

-0.5 (-1.43%)

DAL Delta Air Lines
$30.63 /

-0.15 (-0.49%)

Hot Stocks
Mylan, Pfizer announce FTC clearance for proposed Upjohn combination » 13:25
10/30/20
10/30
13:25
10/30/20
13:25
MYL

Mylan

$14.57 /

+0.19 (+1.32%)

, PFE

Pfizer

$34.99 /

-0.285 (-0.81%)

Mylan (MYL) and Pfizer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFE Pfizer
$34.99 /

-0.285 (-0.81%)

MYL Mylan
$14.57 /

+0.19 (+1.32%)

MYL Mylan
$14.57 /

+0.19 (+1.32%)

09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
09/16/20 Raymond James
Mylan exclusivity on Tecfidera generic abruptly ending, says Raymond James
08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
PFE Pfizer
$34.99 /

-0.285 (-0.81%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
10/23/20 Truist
Pfizer initiated with a Buy at Truist
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
PFE Pfizer
$34.99 /

-0.285 (-0.81%)

MYL Mylan
$14.57 /

+0.19 (+1.32%)

PFE Pfizer
$34.99 /

-0.285 (-0.81%)

MYL Mylan
$14.57 /

+0.19 (+1.32%)

PFE Pfizer
$34.99 /

-0.285 (-0.81%)

MYL Mylan
$14.57 /

+0.19 (+1.32%)

PFE Pfizer
$34.99 /

-0.285 (-0.81%)

MYL Mylan
$14.57 /

+0.19 (+1.32%)

Hot Stocks
Pfizer, Mylan agree to divestitures for Upjohn deal, FTC says » 12:28
10/30/20
10/30
12:28
10/30/20
12:28
PFE

Pfizer

$35.06 /

-0.215 (-0.61%)

, MYL

Mylan

$14.59 /

+0.21 (+1.46%)

Pfizer (PFE) and Mylan…

Pfizer (PFE) and Mylan (MYL) have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn and Mylan will harm current or future competition in ten generic drug markets, the FTC said in a statement. Under the proposed deal, Pfizer will spin off its Upjohn division, which includes Pfizer's authorized generic business Greenstone, and combine it with Mylan. The new entity will be called Viatris. Pfizer will receive $12B from Viatris as partial consideration for the Upjohn spin-off. The FTC's complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers. The proposed settlement seeks to remedy competitive concerns in ten generic pharmaceutical markets by requiring the parties to divest to Prasco, the rights and assets related to Upjohn's amlodipine besylate/atorvastatin calcium tablets, phenytoin chewable tablets, prazosin HCl capsules, spironolactone HCTZ tablets, gatifloxacin ophthalmic solution, and medroxyprogesterone acetate injectable solution. The parties must also divest the rights and assets related to Mylan's eplerenone tablets.

ShowHide Related Items >><<
PFE Pfizer
$35.06 /

-0.215 (-0.61%)

MYL Mylan
$14.59 /

+0.21 (+1.46%)

PFE Pfizer
$35.06 /

-0.215 (-0.61%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
10/23/20 Truist
Pfizer initiated with a Buy at Truist
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
MYL Mylan
$14.59 /

+0.21 (+1.46%)

09/17/20 Morgan Stanley
Court ruling eliminates hurdle for Tecfidera generics, says Morgan Stanley
09/16/20 Raymond James
Mylan exclusivity on Tecfidera generic abruptly ending, says Raymond James
08/19/20 Piper Sandler
Mylan launch puts 30% of Biogen revenue base at risk, says Piper Sandler
07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
PFE Pfizer
$35.06 /

-0.215 (-0.61%)

MYL Mylan
$14.59 /

+0.21 (+1.46%)

PFE Pfizer
$35.06 /

-0.215 (-0.61%)

MYL Mylan
$14.59 /

+0.21 (+1.46%)

PFE Pfizer
$35.06 /

-0.215 (-0.61%)

MYL Mylan
$14.59 /

+0.21 (+1.46%)

PFE Pfizer
$35.06 /

-0.215 (-0.61%)

MYL Mylan
$14.59 /

+0.21 (+1.46%)

Yesterday
Periodicals
Fauci sees first COVID vaccines available in late Dec, early Jan, Reuters says » 18:31
10/29/20
10/29
18:31
10/29/20
18:31
MRNA

Moderna

$71.28 /

+5.53 (+8.41%)

, PFE

Pfizer

$35.27 /

-0.175 (-0.49%)

, SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$329.97 /

+3.28 (+1.00%)

Dr. Anthony Fauci,…

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that, if all goes well, the first doses of a safe and effective COVID-19 vaccine will likely become available to some high-risk Americans in late December or early January, Reuters' Julie Steenhuysen reports. Fauci said in a live chat on Twitter and Facebook that, based on current projections from vaccine developers Moderna (MRNA) and Pfizer (PFE), people in the U.S. will likely know "sometime in December whether or not we have a safe and effective vaccine," the author says. "The first interim look (at trial results) should be, we hope, within the next few weeks," Fauci added. Reference Link

ShowHide Related Items >><<
SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.27 /

-0.175 (-0.49%)

MRNA Moderna
$71.28 /

+5.53 (+8.41%)

MRNA Moderna
$71.28 /

+5.53 (+8.41%)

10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
PFE Pfizer
$35.27 /

-0.175 (-0.49%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
10/23/20 Truist
Pfizer initiated with a Buy at Truist
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
SPX S&P 500
$0.00 /

+ (+0.00%)

09/01/20
Fed's Brainard says monetary policy to pivot from stabilization to accommodation
08/17/20 Goldman Sachs
Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000
06/04/20 Keefe Bruyette
Mattis rebuke 'wake up call' for stock market, says Keefe Bruyette
03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
SPY SPDR S&P 500 ETF Trust
$329.97 /

+3.28 (+1.00%)

PFE Pfizer
$35.27 /

-0.175 (-0.49%)

MRNA Moderna
$71.28 /

+5.53 (+8.41%)

  • 19
    May
  • 12
    Feb
SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.27 /

-0.175 (-0.49%)

MRNA Moderna
$71.28 /

+5.53 (+8.41%)

PFE Pfizer
$35.27 /

-0.175 (-0.49%)

MRNA Moderna
$71.28 /

+5.53 (+8.41%)

SPY SPDR S&P 500 ETF Trust
$329.97 /

+3.28 (+1.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

PFE Pfizer
$35.27 /

-0.175 (-0.49%)

MRNA Moderna
$71.28 /

+5.53 (+8.41%)

SPY SPDR S&P 500 ETF Trust
$329.97 /

+3.28 (+1.00%)

SPX S&P 500
$0.00 /

+ (+0.00%)

Hot Stocks
Nikola appoints Bruce Smith to Board of Directors » 17:01
10/29/20
10/29
17:01
10/29/20
17:01
NKLA

Nikola

$19.80 /

+0.1 (+0.51%)

Nikola announced that it…

Nikola announced that it has appointed Bruce Smith as a new independent director. Smith has more than 30 years of leadership experience in manufacturing operations, having led numerous companies and has a history of driving business and financial outperformance. He is currently the Chairman and CEO of Detroit Manufacturing Systems.

ShowHide Related Items >><<
NKLA Nikola
$19.80 /

+0.1 (+0.51%)

NKLA Nikola
$19.80 /

+0.1 (+0.51%)

10/29/20 Wedbush
General Motors could be major player in EV market with Tesla, says Wedbush
10/19/20 JPMorgan
Nikola, GM partnership still likely by December 3, says JPMorgan
10/13/20 Deutsche Bank
Nikola price target lowered to $26 from $29 at Deutsche Bank
10/12/20 JPMorgan
Nikola hydrogen day 'helpful' in restoring confidence, says JPMorgan
NKLA Nikola
$19.80 /

+0.1 (+0.51%)

NKLA Nikola
$19.80 /

+0.1 (+0.51%)

NKLA Nikola
$19.80 /

+0.1 (+0.51%)

NKLA Nikola
$19.80 /

+0.1 (+0.51%)

Initiation
Fly Intel: Top five analyst initiations » 09:51
10/29/20
10/29
09:51
10/29/20
09:51
BNTX

BioNTech

$79.99 /

+2.36 (+3.04%)

, ANGI

Angi Homeservices

$10.77 /

+0.115 (+1.08%)

, ADCT

ADC Therapeutics

$28.99 /

+0.36 (+1.26%)

, MRTX

Mirati Therapeutics

$203.41 /

+1.02 (+0.50%)

, SVC

Service Properties

$6.95 /

-0.155 (-2.18%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. BioNTech (BNTX) initiated with a Buy at Commerzbank. 2. Angi Homeservices (ANGI) initiated with an Outperform at Credit Suisse. 3. ADC Therapeutics (ADCT) initiated with a Buy at H.C. Wainwright. 4. Mirati Therapeutics (MRTX) reinstated with an Outperform at Credit Suisse. 5. Service Properties (SVC) initiated with a Neutral at BTIG. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SVC Service Properties
$6.95 /

-0.155 (-2.18%)

MRTX Mirati Therapeutics
$203.41 /

+1.02 (+0.50%)

BNTX BioNTech
$79.99 /

+2.36 (+3.04%)

ANGI Angi Homeservices
$10.77 /

+0.115 (+1.08%)

ADCT ADC Therapeutics
$28.99 /

+0.36 (+1.26%)

BNTX BioNTech
$79.99 /

+2.36 (+3.04%)

10/29/20 Commerzbank
BioNTech initiated with a Buy at Commerzbank
10/14/20 SVB Leerink
BioNTech price target raised to $69 from $62 at SVB Leerink
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
ANGI Angi Homeservices
$10.77 /

+0.115 (+1.08%)

10/29/20 Credit Suisse
IAC price target raised to $199 from $160 at Credit Suisse
10/29/20 Credit Suisse
Angi Homeservices initiated with an Outperform at Credit Suisse
09/24/20 Piper Sandler
Angi Homeservices initiated with a Neutral at Piper Sandler
09/15/20 Jefferies
IAC's key segments saw sequential acceleration in August, says Jefferies
ADCT ADC Therapeutics
$28.99 /

+0.36 (+1.26%)

10/29/20 H.C. Wainwright
ADC Therapeutics initiated with a Buy at H.C. Wainwright
06/09/20 Morgan Stanley
ADC Therapeutics initiated with an Overweight at Morgan Stanley
06/09/20 Cowen
ADC Therapeutics initiated with an Outperform at Cowen
06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA
MRTX Mirati Therapeutics
$203.41 /

+1.02 (+0.50%)

10/29/20 Barclays
Mirati Therapeutics price target raised to $244 from $143 at Barclays
10/29/20 Credit Suisse
Mirati Therapeutics reinstated with an Outperform at Credit Suisse
10/26/20 SVB Leerink
Mirati Therapeutics price target raised to $195 from $134 at SVB Leerink
10/26/20 Oppenheimer
Mirati Therapeutics price target raised to $225 from $190 at Oppenheimer
SVC Service Properties
$6.95 /

-0.155 (-2.18%)

10/29/20 BTIG
Service Properties initiated with a Neutral at BTIG
10/21/20 B. Riley Securities
Service Properties price target lowered to $12 from $14 at B. Riley Securities
06/05/20 B. Riley Securities
Braemar Hotels downgraded to Neutral on valuaton at B. Riley FBR
05/12/20 B. Riley Securities
Service Properties price target lowered to $13 from $17 at B. Riley FBR
MRTX Mirati Therapeutics
$203.41 /

+1.02 (+0.50%)

BNTX BioNTech
$79.99 /

+2.36 (+3.04%)

ANGI Angi Homeservices
$10.77 /

+0.115 (+1.08%)

ADCT ADC Therapeutics
$28.99 /

+0.36 (+1.26%)

  • 28
    Oct
  • 24
    Sep
  • 23
    Jul
  • 15
    May
  • 06
    Feb
  • 10
    Jan
BNTX BioNTech
$79.99 /

+2.36 (+3.04%)

MRTX Mirati Therapeutics
$203.41 /

+1.02 (+0.50%)

BNTX BioNTech
$79.99 /

+2.36 (+3.04%)

ANGI Angi Homeservices
$10.77 /

+0.115 (+1.08%)

BNTX BioNTech
$79.99 /

+2.36 (+3.04%)

ANGI Angi Homeservices
$10.77 /

+0.115 (+1.08%)

ADCT ADC Therapeutics
$28.99 /

+0.36 (+1.26%)

Recommendations
General Motors could be major player in EV market with Tesla, says Wedbush » 09:30
10/29/20
10/29
09:30
10/29/20
09:30
GM

General Motors

$34.10 /

-0.79 (-2.26%)

, TSLA

Tesla

$406.00 /

-18.6 (-4.38%)

, NKLA

Nikola

$19.69 /

-1.75 (-8.16%)

Wedbush analyst Daniel…

Wedbush analyst Daniel Ives notes that General Motors (GM) is officially entering the electric pickup race and throwing its hat in the ring with GMC Hummer EV with more details released over the past week. The GMC Hummer EV is slated to go on sale with an initial launch slated for next Fall 2021 with a high sticker price of roughly $113k, he notes. While reservations are initially sold out, the analyst believes broadly this vehicle could see relatively strong demand out of the gates given the initial specs and the massive market opportunity ahead on the EV front. Competition wise, GM - as well as Nikola (NKLA) with the Badger - are going after Tesla (TSLA) and its Cybertruck, which Ives believe is on a path to 700k pre-orders.

ShowHide Related Items >><<
TSLA Tesla
$406.00 /

-18.6 (-4.38%)

NKLA Nikola
$19.69 /

-1.75 (-8.16%)

GM General Motors
$34.10 /

-0.79 (-2.26%)

GM General Motors
$34.10 /

-0.79 (-2.26%)

10/22/20 JPMorgan
General Motors price target raised to $44 from $36 at JPMorgan
10/22/20 Barclays
General Motors price target raised to $40 from $39 at Barclays
10/21/20 Morgan Stanley
Morgan Stanley highlights five reasons for General Motors' advance
10/20/20 Citi
Ford price target raised to $9 from $7.50 at Citi
TSLA Tesla
$406.00 /

-18.6 (-4.38%)

10/27/20 Citi
Tesla price target raised to $137 from $117 at Citi
10/25/20 GLJ Research
China Tesla car recall seems 'a pretty big deal,' says GLJ Research
10/23/20 Morgan Stanley
Tesla price target raised to $360 from $333 at Morgan Stanley
10/22/20
Fly Intel: Top five analyst upgrades
NKLA Nikola
$19.69 /

-1.75 (-8.16%)

10/19/20 JPMorgan
Nikola, GM partnership still likely by December 3, says JPMorgan
10/13/20 Deutsche Bank
Nikola price target lowered to $26 from $29 at Deutsche Bank
10/12/20 JPMorgan
Nikola hydrogen day 'helpful' in restoring confidence, says JPMorgan
09/24/20
Fly Intel: Top five analyst downgrades
TSLA Tesla
$406.00 /

-18.6 (-4.38%)

NKLA Nikola
$19.69 /

-1.75 (-8.16%)

GM General Motors
$34.10 /

-0.79 (-2.26%)

  • 14
    Feb
TSLA Tesla
$406.00 /

-18.6 (-4.38%)

NKLA Nikola
$19.69 /

-1.75 (-8.16%)

GM General Motors
$34.10 /

-0.79 (-2.26%)

TSLA Tesla
$406.00 /

-18.6 (-4.38%)

NKLA Nikola
$19.69 /

-1.75 (-8.16%)

GM General Motors
$34.10 /

-0.79 (-2.26%)

TSLA Tesla
$406.00 /

-18.6 (-4.38%)

NKLA Nikola
$19.69 /

-1.75 (-8.16%)

GM General Motors
$34.10 /

-0.79 (-2.26%)

Earnings
Volkswagen reports Q3 EPS EUR 5.17 vs. EUR 7.56 last year » 06:22
10/29/20
10/29
06:22
10/29/20
06:22
VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Reports Q3 revenue EUR…

Reports Q3 revenue EUR 155.5B vs. EUR186.6B last year. Reports Q3 worldwide deliveries down 18.7% at 6.5M vehicles. The company states: "The global spread of the SARS-CoV-2 virus, the associated restrictions and the resulting downturn in demand and supply meant that growth in the world economy was nega-tive between January and September 2020. The average rate of expansion of gross domestic product (GDP) was far below the previous year's level in both the advanced economies and the emerging markets. However, it was evident worldwide that growth rates declined less sharply in the third quarter of this year than in the second quarter. At country level, perfor-mance in the reporting period depended on the extent to which the negative impacts of the global Covid-19 pandemic were already materializing... The Volkswagen Group delivered 6,504,747 vehicles to cus-tomers worldwide from January to September 2020. The decrease of 18.7% or 1,500,419 units year-on-year was due almost exclusively to the Covid-19 pandemic and the measures taken worldwide to contain its spread. " Reference Link

ShowHide Related Items >><<
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

10/22/20 Morgan Stanley
Volkswagen price target raised to EUR 148 from EUR 135 at Morgan Stanley
10/21/20 Societe Generale
Volkswagen price target raised to EUR 190 from EUR 184 at Societe Generale
10/19/20 Goldman Sachs
Volkswagen price target raised to EUR 179 from EUR 169 at Goldman Sachs
10/15/20 UBS
Volkswagen price target raised to EUR 190 from EUR 180 at UBS
VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

VWAGY Volkswagen
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.